Financhill
Sell
5

PLRX Quote, Financials, Valuation and Earnings

Last price:
$1.35
Seasonality move :
-17.68%
Day range:
$1.24 - $1.35
52-week range:
$1.24 - $16.52
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
16.14x
P/B ratio:
0.27x
Volume:
1.4M
Avg. volume:
3M
1-year change:
-90.79%
Market cap:
$82.1M
Revenue:
$1.6M
EPS (TTM):
-$3.47

Earnings Data

Next earnings date for PLRX
May 06
2025
Most recent earnings per share
-$0.82
Beat by $0.14
(Mar 3/2025)
Consensus Estimate
-$0.96
(Mar 3/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PLRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 -- -- -- -$0.62 --
05/06/2025 Q1 -- -- -- -$0.75 --
03/03/2025 Q4 -- -- -$0.82 -$0.96 $0.14
11/07/2024 Q3 $354.2K -- -$0.95 -$0.98 $0.03
08/07/2024 Q2 $399.6K -- -$0.92 -$0.85 -$0.07
05/06/2024 Q1 $387.1K -- -$0.78 -$0.77 -$0.01
02/27/2024 Q4 $458.3K -- -$0.69 -$0.82 $0.13
11/09/2023 Q3 -- -- -$0.70 -$0.77 $0.07
08/09/2023 Q2 -- -- -$0.70 -$0.69 -$0.01
05/09/2023 Q1 -- -- -$0.67 -$0.67 --
03/09/2023 Q4 -- -- -$0.72 -$0.70 -$0.02
11/08/2022 Q3 -- -- -$0.65 -$0.74 $0.09
08/08/2022 Q2 -- -- -$0.82 -$0.81 -$0.01
05/09/2022 Q1 -- -- -$0.78 -$0.74 -$0.04
02/28/2022 Q4 -- -- -$0.68 -$0.75 $0.07
11/09/2021 Q3 -- -- -$0.75 -$0.69 -$0.06
08/09/2021 Q2 -- -- -$0.64 -$0.67 $0.03
05/10/2021 Q1 -- -- -$0.64 -$0.60 -$0.04
03/16/2021 Q4 -- -- -$0.54 -$0.60 $0.06
11/10/2020 Q3 -- -- -$0.47 -$0.60 $0.13
08/11/2020 Q2 -- -- -$1.39 -$0.68 -$0.71
03/31/2020 Q1 -- -- -- -- --
12/31/2019 Q4 -- -- $1.75 -- --
09/30/2019 Q3 -- -- -$0.67 -- --
06/30/2019 Q2 -- -- -$0.77 -- --
03/31/2019 Q1 -- -- -$0.70 -- --

Pliant Therapeutics Earnings Questions

  • How Much did Pliant Therapeutics Generate in Revenue Last Quarter?

    Pliant Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Pliant Therapeutics Beat Earnings Last Quarter?

    Pliant Therapeutics announced earnings per share of -$0.82 which represents a beat of analyst forecast a -$0.96 per share.

  • Is Pliant Therapeutics Profitable?

    Pliant Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Pliant Therapeutics EPS Next Year?

    Pliant Therapeutics's earnings are forecast to decrease from -$3.47 per share to -$3.56 per share next year representing a decrease of -13.78%.

  • When is Pliant Therapeutics's Earnings Date?

    Pliant Therapeutics's next earnings date is May 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Do I Need to Know About Alcoa Stock?
What Do I Need to Know About Alcoa Stock?

Alcoa (AA) is a global leader in aluminum production. Based…

Is ROOT Stock the Next Big Thing?
Is ROOT Stock the Next Big Thing?

Root Holdings (NASDAQ:ROOT) is the parent company of Root Insurance,…

Is Okta a Good Stock to Buy?
Is Okta a Good Stock to Buy?

Okta (NASDAQ:OKTA) is used by some of the largest firms…

Stock Ideas

Sell
37
Is AAPL Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 31x

Sell
37
Is MSFT Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 30x

Sell
31
Is NVDA Stock a Buy?

Market Cap: $2.3T
P/E Ratio: 32x

Alerts

Sell
45
RGC alert for Apr 7

Regencell Bioscience Holdings [RGC] is down 1.12% over the past day.

Sell
25
GDXU alert for Apr 7

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 1.69% over the past day.

Buy
76
SOXS alert for Apr 7

Direxion Daily Semiconductor Bear 3X Shares [SOXS] is down 0.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock